Nanobiotix (NBTX) Total Liabilities (2018 - 2025)

Nanobiotix's Total Liabilities history runs 8 years deep, the most recent figure standing at $177.2 million for Q4 2025.

• On a quarterly basis, Total Liabilities rose 24.58% year-over-year to $177.2 million in Q4 2025; TTM through Dec 2025 was $177.2 million, a 24.58% increase from a year earlier, with the FY2025 full-year figure at $172.0 million, up 20.91% from the prior year.
• Total Liabilities grew to $177.2 million in Q4 2025 per NBTX's latest filing, from $129.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $177.2 million in Q4 2025 and bottomed at $58.0 million in Q2 2022.
• The 5-year median for Total Liabilities is $109.7 million (2021), against an average of $105.6 million.
• Across the five-year window, Total Liabilities tumbled 47.62% in 2022 and surged 68.93% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $116.4 million in 2021, then slumped by 47.62% to $61.0 million in 2022, then surged by 68.93% to $103.0 million in 2023, then jumped by 38.1% to $142.3 million in 2024, then climbed by 24.58% to $177.2 million in 2025.
• Per Business Quant, the three latest NBTX Total Liabilities figures stand at $177.2 million (Q4 2025), $129.2 million (Q2 2025), and $142.3 million (Q4 2024).